Skip to main content

Laboratory of Clinical Investigation

Josephine Egan, MD, Chief

The Laboratory of Clinical Investigation (LCI) is comprised of 3 Sections with 4 principal investigators. These are as follows: Bioanalytical Chemistry and Drug Discovery Section; Diabetes Section; and Magnetic Resonance Imaging and Spectroscopy Section. The common theme and thread among these research groups is that of the identification and development of new therapeutic targets for the treatment of age-related disease. The Laboratory serves as an infrastructure to facilitate the creation and development of therapeutic targets within the Laboratory and across the Intramural Research Program.

Portfolio/Research Areas

  • Bioanalytical Chemistry
  • Drug Discovery
  • Diabetes
  • Magnetic Resonance Imaging and Spectroscopy

Units/Sections

Magnetic Resonance Imaging and Spectroscopy Section
Diabetes Section
Lipid Mediators, Inflammation, and Pain Unit
Lymphocyte Development Section
NIA Clinical Core Laboratory & Biorepository
3T Imaging Facility

Laboratory of Clinical Investigation Staff